Singapore markets close in 6 hours 2 minutes

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.77-0.07 (-0.47%)
At close: 04:00PM EDT
15.15 +0.38 (+2.57%)
After hours: 04:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.84
Open14.77
Bid14.00 x 1200
Ask14.77 x 1000
Day's range14.29 - 15.10
52-week range8.06 - 35.75
Volume181,174
Avg. volume871,729
Market cap618.777M
Beta (5Y monthly)0.92
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Repare Therapeutics to Participate at the Goldman Sachs 43rd Annual Global Healthcare Conference

    CAMBRIDGE, Mass. & MONTREAL, June 07, 2022--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022 at 03:20 p.m. Pacific Time/ 6:20 p.m. Eastern Time in Rancho Palos Verdes, CA.

  • Business Wire

    Repare Therapeutics Announces a Worldwide License and Collaboration Agreement with Roche for Camonsertib (RP-3500)

    CAMBRIDGE, Mass. & MONTREAL, June 01, 2022--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib (also known as RP-3500), a potent and selective oral small molecule inhibitor of ATR (Ataxia-Telangiectasia and Rad3-related protein kinase) for the treatment of tumors with specific

  • Business Wire

    Repare Therapeutics to Participate at the 2022 Guggenheim Synthetic Lethality Day

    CAMBRIDGE, Mass. & MONTREAL, May 09, 2022--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the virtual 2022 Guggenheim Synthetic Lethality Day on Monday, May 16, 2022 at 9:00 a.m. Eastern Time.